OrthoPediatrics (NASDAQ:KIDS) Shares Down 5.4% – Time to Sell?

OrthoPediatrics Corp. (NASDAQ:KIDS) dropped 5.4% during mid-day trading on Tuesday . The company traded as low as $25.09 and last traded at $25.18. Approximately 36,370 shares traded hands during mid-day trading, a decline of 78% from the average daily volume of 168,215 shares. The stock had previously closed at $26.61.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on KIDS. Truist Financial dropped their target price on OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating on the stock in a research report on Monday, October 14th. JMP Securities reaffirmed a “market outperform” rating and issued a $50.00 price target on shares of OrthoPediatrics in a report on Friday, September 13th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $42.00 target price on shares of OrthoPediatrics in a report on Friday, November 8th.

OrthoPediatrics Stock Down 1.5 %

The stock has a market capitalization of $635.05 million, a price-to-earnings ratio of -21.63 and a beta of 1.16. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. The business has a 50-day moving average of $26.36 and a 200-day moving average of $29.24.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. Quarry LP purchased a new position in shares of OrthoPediatrics in the third quarter valued at $25,000. International Assets Investment Management LLC raised its holdings in OrthoPediatrics by 2,610.8% in the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after buying an additional 966 shares during the period. Quest Partners LLC acquired a new position in shares of OrthoPediatrics during the second quarter worth about $34,000. BNP Paribas Financial Markets grew its position in OrthoPediatrics by 125.1% in the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock valued at $94,000 after acquiring an additional 1,929 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new stake in OrthoPediatrics during the 2nd quarter worth $110,000. Institutional investors and hedge funds own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.